...Anna Gurevich-Shapiro; Sharon Tzadok; Alina Rosenberg; Aida Inbal; Michal Bar-Natan; Ofir Wolach; Pia Raanani Background: Refractoriness to platelet transfusion, prevalent among 15-20% of hemato-oncological patients, is associated with multitransfusions and inferior outcomes. We evaluated...

... at 20-22 °C without agitation. It appears that these platelets presently allow to respond to the increasing clinical demands for platelet transfusion despite the partial loss of their biochemical and functional properties. Material and Methods Normal human venous blood was collected in plastic bags...

.... The remaining 7 patients (54%) underwent complete remission (CR) with daunomycin, arabinosyl cytosine, and adriamycin. All patients received massive platelet transfusion, no heparin, and no granulocyte transfusion. CR was more frequent in patients with a very low blast cell count and a fibrinogen level higher...

..., instructions or products referred to in the content or advertisements. β -Thromboglobulin Platelet factor 4 Platelet transfusion Platelets Original Papers Acta haemat. 64: 1-5 (1980) Plasma Levels of Thromboglobulin and Platelet Factor 4 in Relation to the Venous Platelet Concentration Jack Kutti...